APTO

Quote

Short

News

Articles

Message Board

Expected earnings - Aptose Biosciences Inc.

August 14, 2025 05:31:33 am

Source: US Earnings Reports

Aptose Biosciences Inc. (APTO) is expected to report for Q2 2025

Aptose Biosciences Inc.

NASDAQ: APTO

APTO Trading

-16.37% G/L:

$1.71 Last:

670,384 Volume:

$1.99 Open:

mwn-alerts Ad 300

APTO Latest News

August 14, 2025 07:00:57 am

Expected US Company Earnings on Thursday, August 14th, 2025

August 14, 2025 05:31:33 am

Expected earnings - Aptose Biosciences Inc.

May 13, 2025 07:00:38 am

Expected US Company Earnings on Tuesday, May 13th, 2025

May 05, 2025 07:00:00 am

Aptose Provides Clinical Update for the Tuspetinib-based Triple Drug Frontline Therapy in Newly Diagnosed AML Patients from the Phase 1/2 TUSCANY Trial

APTO Stock Data

Market Cap $4,253,813

Float 2,003,657

Insiders Ownership 27.37%

Institutions 8

Short Percent 69835%

Industry Biotechnology & Life Sciences

Sector Healthcare

Website https://www.aptose.com

Country CA

City Toronto

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App